{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:32:38Z","timestamp":1793039558936,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.neuroscience.2026.01.010","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:22:11Z","timestamp":1768004531000},"page":"143-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A multi-target therapeutic framework for Alzheimer\u2019s disease: an integrative mechanistic review"],"prefix":"10.1016","volume":"596","author":[{"given":"Ousman","family":"Bajinka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5816-2835","authenticated-orcid":false,"given":"Lamarana","family":"Jallow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7577-4233","authenticated-orcid":false,"given":"Guven","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2026.01.010_b0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gde.2016.04.006","article-title":"Mitochondria-associated ER membranes and Alzheimer disease","volume":"38","author":"Area-Gomez","year":"2016","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.01.010_b0010","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s00259-021-05253-y","article-title":"The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers","volume":"48","author":"Ashton","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neuroscience.2026.01.010_b0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neurobiolaging.2019.09.008","article-title":"What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons","volume":"85","author":"Babiloni","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1684\/mrh.2011.0287","article-title":"Altered ionized magnesium levels in mild-to-moderate Alzheimer's disease","volume":"24","author":"Barbagallo","year":"2011","journal-title":"Magnes. Res."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease","volume":"26","author":"Barthelemy","year":"2020","journal-title":"Nat. Med."},{"issue":"7399","key":"10.1016\/j.neuroscience.2026.01.010_b0030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.01.010_b0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/0271678X16631756","article-title":"Magnetic resonance imaging for assessment of cerebrovascular reactivity in cerebral small vessel disease: a systematic review","volume":"39","author":"Blair","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"5\u20136","key":"10.1016\/j.neuroscience.2026.01.010_b0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neucli.2010.08.001","article-title":"Revisiting P300 cognitive studies for dementia diagnosis: early dementia with Lewy bodies (DLB) and Alzheimer disease (AD)","volume":"40","author":"Bonanni","year":"2010","journal-title":"Clin. Neurophysiol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ana.25123","article-title":"Person-specific contribution of neuropathologies to cognitive loss in old age","volume":"83","author":"Boyle","year":"2018","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.01.010_b0050","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0460.1000450","article-title":"Reversal of cognitive decline: 100 patients","volume":"8","author":"Bredesen","year":"2018","journal-title":"J. Alzheimers Dis Parkinsonism."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.01.010_b0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","article-title":"Depression and risk of developing dementia","volume":"7","author":"Byers","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.01.010_b0065","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3233\/JAD-180263","article-title":"Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis","volume":"65","author":"Campbell","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"16","key":"10.1016\/j.neuroscience.2026.01.010_b0070","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/WNL.0000000000003227","article-title":"Thyroid function and the risk of dementia: The Rotterdam Study","volume":"87","author":"Chaker","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neuroscience.2026.01.010_b0075","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","article-title":"Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging","volume":"78","author":"Chen","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fnagi.2014.00004","article-title":"Dietary mineral intake and risk of mild cognitive impairment: the PATH through Life project","volume":"6","author":"Cherbuin","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0085","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-141791","article-title":"Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia","volume":"44","author":"Claxton","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1192\/bjp.bp.113.127811","article-title":"Treatment for mild cognitive impairment: systematic review","volume":"203","author":"Cooper","year":"2013","journal-title":"Br. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.01.010_b0095","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0100","article-title":"Alzheimer's disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimers Dement (N Y)."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fnmol.2016.00053","article-title":"Can ketones help rescue brain fuel supply in later life? Implications for cognitive health during aging and the treatment of Alzheimer's disease","volume":"9","author":"Cunnane","year":"2016","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.01.010_b0110","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/SLA.0000000000002684","article-title":"CSF beta-amyloid 1-42 concentration predicts delirium following elective arthroplasty surgery in an observational cohort study","volume":"269","author":"Cunningham","year":"2019","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.01.010_b0115","first-page":"1088","article-title":"Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer\u2019s disease","volume":"30","author":"Davies","year":"2020","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.01.010_b0120","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.4161\/hv.27882","article-title":"Immunotherapy for Alzheimer's disease: DNA-and protein-based epitope vaccines","volume":"10","author":"Davtyan","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.01.010_b0125","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.18632\/aging.102810","article-title":"Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer's disease or mild cognitive impairment\u2014a meta-analysis of randomized controlled trials","volume":"12","author":"Den","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.01.010_b0130","first-page":"2536","article-title":"Tau reduction in the presence of amyloid-\u03b2 prevents tau pathology and neuronal death in vivo","volume":"146","author":"DeVos","year":"2023","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.01.010_b0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1192\/bjp.bp.112.118307","article-title":"Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies","volume":"202","author":"Diniz","year":"2013","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.01.010_b0140","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0145","first-page":"246","article-title":"Early detection of Alzheimer's disease with blood plasma proteins using a panel of machine learning and statistical models","volume":"22","author":"Eke","year":"2021","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0150","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002854.pub4","article-title":"Vitamin E for Alzheimer's dementia and mild cognitive impairment","volume":"1(1):CD002854","author":"Farina","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.01.010_b0155","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","article-title":"Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study","volume":"11","author":"Fiandaca","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7326\/M17-1529","article-title":"Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer's-type dementia: a systematic review","volume":"168","author":"Fink","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fnagi.2018.00299","article-title":"Jigsaw puzzling taps multiple cognitive abilities and is a potential protective factor for cognitive aging","volume":"10","author":"Fissler","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0170","first-page":"479","article-title":"Association of plasma neurofilament light with postoperative delirium","volume":"86","author":"Fong","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0175","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2147\/CIA.S72728","article-title":"Efficacy and tolerability of Ginkgo biloba extract EGb 761\u00ae in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"9","author":"Gauthier","year":"2014","journal-title":"Clin. Interv. Aging"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/WNL.0000000000001702","article-title":"Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease","volume":"85","author":"Goetzl","year":"2015","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neuroscience.2026.01.010_b0185","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","article-title":"Tau positron emission tomographic imaging in the Lewy body diseases","volume":"73","author":"Gomperts","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101529","article-title":"Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria","volume":"73","author":"Gowda","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.01.010_b0195","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/advances\/nmaa073","article-title":"To keto or not to keto? A systematic review of randomized controlled trials assessing the effects of ketogenic therapy on Alzheimer disease","volume":"11","author":"Grammatikopoulou","year":"2020","journal-title":"Adv. Nutr."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/BJ20121753","article-title":"Physiological and pathological roles of mitochondrial SLC25 carriers","volume":"454","author":"Guti\u00e9rrez-Aguilar","year":"2013","journal-title":"Biochem. J"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0205","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/molecules24030648","article-title":"Hesperidin as a neuroprotective agent: a review of animal and clinical evidence","volume":"24","author":"Hajialyani","year":"2019","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.neuroscience.2026.01.010_b0210","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer's disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.01.010_b0215","first-page":"312","article-title":"The rising importance of neuroinflammation in Alzheimer's disease: diagnostic and therapeutic implications","volume":"22","author":"Hampel","year":"2023","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","article-title":"Advantages and disadvantages of the use of the CSF Amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer's disease","volume":"11","author":"Hansson","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0225","article-title":"Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations","volume":"4(4):CD010079","author":"Harrison","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.01.010_b0230","article-title":"Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation: a case report","volume":"48","author":"Hazan","year":"2020","journal-title":"J. Int. Med. Res."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.01.010_b0235","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.01.010_b0240","first-page":"611","article-title":"Discovery and identification of an endogenous metabolite of tramiprosate and its prodrug ALZ-801 that inhibits beta amyloid oligomer formation in the human brain","volume":"37","author":"Hey","year":"2023","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.neuroscience.2026.01.010_b0245","first-page":"1943","article-title":"The clinical practice of risk reduction for Alzheimer's disease: a precision medicine approach","volume":"17","author":"Isaacson","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0250","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-1-4939-3023-4_40","article-title":"Effect of the antioxidant supplement pyrroloquinoline quinone disodium salt (BioPQQ\u2122) on cognitive functions","volume":"876","author":"Itoh","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.01.010_b0255","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"23","key":"10.1016\/j.neuroscience.2026.01.010_b0260","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1001\/jama.2019.7437","article-title":"Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia","volume":"321","author":"Jack","year":"2019","journal-title":"J. Am. Med. Assoc."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.01.010_b0265","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1212\/WNL.0000000000006082","article-title":"CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease","volume":"91","author":"Janelidze","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0270","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","article-title":"Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease","volume":"11","author":"Janelidze","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0275","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","article-title":"Associations of plasma phospho-Tau217 levels with tau positron emission tomography in early Alzheimer disease","volume":"78","author":"Janelidze","year":"2020","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0280","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","article-title":"Practical considerations for choosing a mouse model of Alzheimer's disease","volume":"12","author":"Jankowsky","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.01.010_b0285","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.01.010_b0290","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation","volume":"26","author":"Johnson","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0295","article-title":"Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association","volume":"9(1):e-1-e-16","author":"Johnson","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0300","first-page":"62","article-title":"Multimodality imaging characteristics of dementia with Lewy bodies","volume":"55","author":"Kantarci","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0305","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.01.010_b0310","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.01.010_b0315","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.01.010_b0320","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.01.010_b0325","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41582-018-0070-3","article-title":"Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease","volume":"14","author":"Kivipelto","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"Pt 11","key":"10.1016\/j.neuroscience.2026.01.010_b0330","first-page":"3373","article-title":"Cerebrospinal fluid levels of the synaptic protein neurogranin in Alzheimer's disease","volume":"138","author":"Kvartsberg","year":"2015","journal-title":"Brain"},{"issue":"41","key":"10.1016\/j.neuroscience.2026.01.010_b0335","doi-asserted-by":"crossref","first-page":"14080","DOI":"10.1523\/JNEUROSCI.3359-12.2012","article-title":"Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes","volume":"32","author":"Lane","year":"2012","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0340","first-page":"81","article-title":"Extra-virgin olive oil improves cognition and neuropathology of the 3xTg-AD mice","volume":"58","author":"Lauretti","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0345","first-page":"33","article-title":"The role of adipokines in Alzheimer's disease","volume":"33","author":"Letra","year":"2022","journal-title":"Curr. Opin. Lipidol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0350","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: one drug, many effects","volume":"19","author":"Li","year":"2014","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0355","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"10248","key":"10.1016\/j.neuroscience.2026.01.010_b0360","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0365","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JAD-150493","article-title":"Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial","volume":"51","author":"Luchsinger","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.01.010_b0370","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/jnnp-2012-302589","article-title":"Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-\u03b2 peptide and \u03c4 levels: target engagement, tolerability and pharmacokinetics in humans","volume":"83","author":"Maccecchini","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.01.010_b0375","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1038\/ncomms11398","article-title":"A two decade dementia incidence comparison from the cognitive function and ageing studies I and II","volume":"7","author":"Matthews","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0380","article-title":"A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease","volume":"6(43):eaaz2387","author":"Mattsson-Carlgren","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0385","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s13668-019-0271-4","article-title":"Diet and inflammation in cognitive ageing and Alzheimer's disease","volume":"8","author":"McGrattan","year":"2019","journal-title":"Curr. Nutr. Rep."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.01.010_b0390","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S2215-0366(16)00097-3","article-title":"10-year trajectories of depressive symptoms and risk of dementia: a population-based study","volume":"3","author":"Mirza","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0395","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0400","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.01.010_b0405","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jalz.2014.11.009","article-title":"MIND diet associated with reduced incidence of Alzheimer's disease","volume":"11","author":"Morris","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"7691","key":"10.1016\/j.neuroscience.2026.01.010_b0410","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.01.010_b0415","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.3390\/ijms21093165","article-title":"Type 3 diabetes and its role implications in Alzheimer's disease","volume":"21","author":"Nguyen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.01.010_b0420","first-page":"919","article-title":"Glial fibrillary acidic protein in serum is increased in Alzheimer's disease and correlates with cognitive impairment","volume":"90","author":"Oeckl","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.01.010_b0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.12.003","article-title":"Toward more predictive genetic mouse models of Alzheimer's disease","volume":"122","author":"Onos","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0430","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13195-024-01482-z","article-title":"Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer\u2019s disease: a randomized, controlled clinical trial","volume":"16","author":"Ornish","year":"2024","journal-title":"Alzheimers Res. Ther."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.01.010_b0435","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2018.12917","article-title":"Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders","volume":"320","author":"Ossenkoppele","year":"2018","journal-title":"J. Am. Med. Assoc."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.01.010_b0440","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.neuroscience.2026.01.010_b0445","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0450","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5483\/BMBRep.2020.53.1.309","article-title":"Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review","volume":"53","author":"Park","year":"2020","journal-title":"BMB Rep."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0455","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/alz.12202","article-title":"Dementia in Latin America: paving the way toward a regional action plan","volume":"17","author":"Parra","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0460","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.dadm.2018.07.004","article-title":"Machine learning of neuroimaging for assisted diagnosis of cognitive impairment and dementia: a systematic review","volume":"10","author":"Pellegrini","year":"2018","journal-title":"Alzheimers Dement (Amst)."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0465","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0197-4580(94)90152-X","article-title":"Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study","volume":"15","author":"Pettegrew","year":"1994","journal-title":"Neurobiol. Aging"},{"issue":"22","key":"10.1016\/j.neuroscience.2026.01.010_b0470","first-page":"12342","article-title":"Mitochondrial transplantation: a new strategy in neurodegenerative diseases","volume":"22","author":"Picone","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 11","key":"10.1016\/j.neuroscience.2026.01.010_b0475","first-page":"3393","article-title":"Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease","volume":"138","author":"Portelius","year":"2015","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0480","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jalz.2017.07.757","article-title":"Association of midlife lipids with 20-year cognitive change: a cohort study","volume":"14","author":"Power","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.01.010_b0485","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2009.02.013","article-title":"Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders","volume":"67","author":"Profenno","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.01.010_b0490","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/brain\/awaa137","article-title":"Development and validation of an interpretable deep learning framework for Alzheimer's disease classification","volume":"143","author":"Qiu","year":"2020","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.01.010_b0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161969","article-title":"Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer's disease phenotypes","volume":"11","author":"Raja","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0500","first-page":"263","article-title":"Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial","volume":"14","author":"Rosenberg","year":"2020","journal-title":"Alzheimers Dement."},{"issue":"17","key":"10.1016\/j.neuroscience.2026.01.010_b0505","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","article-title":"APP mouse models for Alzheimer's disease preclinical studies","volume":"36","author":"Sasaguri","year":"2017","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.01.010_b0510","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(18)30338-7","article-title":"Nutrition and prevention of cognitive impairment","volume":"17","author":"Scarmeas","year":"2018","journal-title":"Lancet Neurol."},{"issue":"10284","key":"10.1016\/j.neuroscience.2026.01.010_b0515","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0520","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/joim.12191","article-title":"Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014","volume":"275","author":"Schneider","year":"2014","journal-title":"J. Intern. Med."},{"issue":"7618","key":"10.1016\/j.neuroscience.2026.01.010_b0525","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0530","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-171042","article-title":"Homocysteine and dementia: an international consensus statement","volume":"62","author":"Smith","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0535","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1750-3639.2008.00188.x","article-title":"Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease","volume":"19","author":"Sokolova","year":"2009","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.01.010_b0540","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","article-title":"Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease","volume":"118","author":"Streit","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0545","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"14","key":"10.1016\/j.neuroscience.2026.01.010_b0550","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archinte.168.14.1514","article-title":"Thyroid function and the risk of Alzheimer disease: the Framingham Study","volume":"168","author":"Tan","year":"2008","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.01.010_b0555","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3945\/ajcn.117.162263","article-title":"A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults","volume":"106","author":"Taylor","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0560","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuroscience.2026.01.010_b0565","doi-asserted-by":"crossref","unstructured":"Tian, J., Jia, K., Wang, T., Guo, L., Xuan, Z., Michaelis, E.K., Swerdlow, R.H., 2024. Alzheimer\u2019s Disease Neuroimaging Initiative; Du H. Hippocampal transcriptome-wide association study and pathway analysis of mitochondrial solute carriers in Alzheimer's disease. Transl Psychiatry. Jun 10;14(1):250. doi: 10.1038\/s41398-024-02958-0.","DOI":"10.1038\/s41398-024-02958-0"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.01.010_b0570","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer's disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.01.010_b0575","first-page":"935","article-title":"The role of genetics in cognitive decline and dementia in diverse populations: a multi-ethnic genome-wide association study","volume":"16","author":"Tosto","year":"2017","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.01.010_b0580","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1468-1331.2010.03194.x","article-title":"Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease","volume":"18","author":"Une","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0585","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.01.010_b0590","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/nu2111106","article-title":"Polyphenols and human health: prevention of disease and mechanisms of action","volume":"2","author":"Vauzour","year":"2010","journal-title":"Nutrients"},{"key":"10.1016\/j.neuroscience.2026.01.010_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110968","article-title":"Traditional Chinese medicine compounds regulate autophagy for treating neurodegenerative disease: a mechanism review","volume":"133","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.01.010_b0600","first-page":"358","article-title":"Associations between CSF cortisol, CSF norepinephrine, and cognition in patients with Alzheimer's disease","volume":"31","author":"Wang","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0605","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13073-016-0355-3","article-title":"Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer\u2019s disease","volume":"8","author":"Wang","year":"2016","journal-title":"Genome Med."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.01.010_b0610","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2174\/1567205011666140812114715","article-title":"Fluoxetine improves behavioral performance by suppressing the production of soluble \u03b2-amyloid in APP\/PS1 mice","volume":"11","author":"Wang","year":"2014","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.01.010_b0615","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/WNL.59.3.364","article-title":"Depressive symptoms, cognitive decline, and risk of AD in older persons","volume":"59","author":"Wilson","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2026.01.010_b0620","article-title":"The therapeutic potential of magnolia-derived neolignans in neurological disorders: a review of preclinical evidence","volume":"14","author":"Woodbury","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.01.010_b0625","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/SLA.0b013e318298b077","article-title":"Cerebrospinal fluid A\u03b2 to tau ratio and postoperative cognitive change","volume":"258","author":"Xie","year":"2013","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.01.010_b0630","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41380-020-0721-9","article-title":"Biomarkers for Alzheimer's disease\u2014preparing for a new era of disease-modifying therapies","volume":"26","author":"Zetterberg","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.01.010_b0635","article-title":"Salidroside ameliorates cognitive impairment in an Alzheimer's mouse model via upregulation of hippocampal BDNF and reduction of oxidative stress","volume":"109","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuroscience.2026.01.010_b0640","first-page":"78","article-title":"Bioenergetic failure in Alzheimer's disease: insights from phosphorus magnetic resonance spectroscopy","volume":"124","author":"Zhu","year":"2023","journal-title":"Neurobiol. Aging"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226000163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226000163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:41:34Z","timestamp":1775900494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226000163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":128,"alternative-id":["S0306452226000163"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.01.010","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multi-target therapeutic framework for Alzheimer\u2019s disease: an integrative mechanistic review","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}